Estela Rodriguez: Great session on ADCs for lung cancer at WCLC24
Estela Rodriguez recently tweeted:
“Saving the best for last! Great session on ADCs for lung cancer starting now at the International Association for the Study of Lung Cancer WCLC24 with co-chairs Ana Velázquez Mañana and Ignatius Ou.
Benjamin Levy starts with what makes these agents different, what are the best targets, why have we seen disappointing trial results compared to docetaxel.”
Source: Estela Rodriguez/X
Estela Rodriguez is Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. She is board certified in medical oncology and hematology. She has a special interest in the early detection of lung cancer and increasing access to clinical trials. Dr. Rodriguez is known to help empower women to take charge of their own healthcare and believes in the power of mentorship.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023